Latest News

The decision expands Imfinzi’s bladder cancer footprint beyond its earlier approval in muscle-invasive bladder cancer (MIBC), where it is used with chemotherapy agents’ gemcitabine and cisplatin before surgery and as a monotherapy afterward.

Under the deal, Blackstone Life Sciences will provide up to US$800 million in exchange for low- to mid-single-digit tiered royalties on future zumilokibart sales for 15 years.

The approval strengthens Abbott’s position in the continuous glucose monitoring (CGM) market and expands its diagnostic capabilities beyond glucose-only tracking, which has traditionally defined wearable diabetes management tools.

The facility, which is expected to begin operations in 2027, will become Align Technology’s first manufacturing site in India and its fourth worldwide.

The appeal followed discussions held during the 79th World Health Assembly (WHA79), where climate-related health risks featured prominently across several agenda items.

The initiative supports Moscow’s broader oncology modernization strategy, which combines investments in diagnostic technology, artificial intelligence, and clinician education to improve patient outcomes.

The collaboration integrates Cercare Medical Neurosuite (CMN), a vendor-neutral imaging platform that provides automated perfusion analysis across CT, MRI, and Cone-Beam CT, with Siemens Healthineers’ Syngo DynaCT Multiphase system.

The ambitious project targets approximately 1.2 million residents, most of whom inhabit rural communities where traditional connectivity has remained inconsistent.

The proposed 50-bed unit at the Laikipia Air Base quarantine facility, scheduled to become operational on May 29

Phesgo, manufactured by Roche, contains a combination of Pertuzumab and Trastuzumab and is used in the treatment of specific types of breast cancer.